Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
INSL4
Introduction
Early placenta insulin-like peptide is a protein that in humans is encoded by the INSL4 gene.[1][2][3]
INSL4 encodes the insulin-like 4 protein, a member of the insulin superfamily. INSL4 encodes a precursor that undergoes post-translational cleavage to produce 3 polypeptide chains, A-C, that form tertiary structures composed of either all three chains, or just the A and B chains. Expression of INSL4 products occurs within the early placental cytotrophoblast and syncytiotrophoblast.[3]
References
References
- ↑ Chassin D, Laurent A, Janneau JL, Berger R, Bellet D (Aug 1996). “Cloning of a new member of the insulin gene superfamily (INSL4) expressed in human placenta”. Genomics. 29 (2): 465–70. doi:10.1006/geno.1995.9980. PMID 8666396.
- ↑ Veitia R, Laurent A, Quintana-Murci L, Ottolenghi C, Fellous M, Vidaud M, McElreavey K (Oct 1998). “The INSL4 gene maps close to WI-5527 at 9p24.1→p23.3 clustered with two relaxin genes and outside the critical region for the monosomy 9p syndrome”. Cytogenet Cell Genet. 81 (3–4): 275–7. doi:10.1159/000015045. PMID 9730618.
- ↑ 3.0 3.1 “Entrez Gene: INSL4 insulin-like 4 (placenta)”.
Further reading
Further reading
- Koman A, Cazaubon S, Couraud PO, et al. (1996). “Molecular characterization and in vitro biological activity of placentin, a new member of the insulin gene family”. J. Biol. Chem. 271 (34): 20238–41. doi:10.1074/jbc.271.34.20238. PMID 8702754.
- Bellet D, Lavaissiere L, Mock P, et al. (1997). “Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta”. J. Clin. Endocrinol. Metab. 82 (9): 3169–72. doi:10.1210/jc.82.9.3169. PMID 9284764.
- Laurent A, Rouillac C, Delezoide AL, et al. (1999). “Insulin-like 4 (INSL4) gene expression in human embryonic and trophoblastic tissues”. Mol. Reprod. Dev. 51 (2): 123–9. doi:10.1002/(SICI)1098-2795(199810)51:2<123::AID-MRD1>3.0.CO;2-S. PMID 9740319.
- Janneau JL, Maldonado-Estrada J, Tachdjian G, et al. (2002). “Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells”. J. Clin. Endocrinol. Metab. 87 (11): 5336–9. doi:10.1210/jc.2002-021093. PMID 12414911.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Bièche I, Laurent A, Laurendeau I, et al. (2004). “Placenta-specific INSL4 expression is mediated by a human endogenous retrovirus element”. Biol. Reprod. 68 (4): 1422–9. doi:10.1095/biolreprod.102.010322. PMID 12606452.
- Humphray SJ, Oliver K, Hunt AR, et al. (2004). “DNA sequence and analysis of human chromosome 9”. Nature. 429 (6990): 369–74. doi:10.1038/nature02465. PMC 2734081. PMID 15164053.
- Zhang Z, Henzel WJ (2005). “Signal peptide prediction based on analysis of experimentally verified cleavage sites”. Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Millar L, Streiner N, Webster L, et al. (2006). “Early placental insulin-like protein (INSL4 or EPIL) in placental and fetal membrane growth”. Biol. Reprod. 73 (4): 695–702. doi:10.1095/biolreprod.105.039859. PMC 1382170. PMID 15958731.